Ignite Creation Date:
2025-12-24 @ 2:41 PM
Ignite Modification Date:
2026-02-03 @ 3:13 AM
Study NCT ID:
NCT04713059
Status:
UNKNOWN
Last Update Posted:
2021-07-01
First Post:
2021-01-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Toripalimab Combined With Anlotinib for Patients With Advanced, Relapsed, or Refractory Gastric, or Esophagogastric Junction Cancer (EGJC)
Sponsor:
The Affiliated Hospital of Qingdao University
Organization: